Dhampur Bio Organics has reported results for fourth quarter (Q4) and year ended March 31, 2023.
Dhampur Bio Organics has reported 18.17% rise in its net profit at Rs 81.95 crore for the quarter under review as compared to Rs 69.35 crore for the same quarter in the previous year. Total income of the company increased by 80.03% at Rs 919.39 crore for Q4FY23 as compared to Rs 510.70 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported rise of 13.02% in its net profit at Rs 80.20 crore for fourth quarter ended March 31, 2023 as compared to Rs 70.96 crore for the same quarter in the previous year. Total income of the company increased by 80.86% at Rs 922.75 crore for Q4FY23 as compared to Rs 510.20 crore for the corresponding quarter previous year.
For the year ended March 31, 2023, the company has reported rise of 7.66% in its net profit at Rs 112.02 crore as compared to Rs 104.05 crore for the previous year. Total income of the company increased by 69.17% at Rs 2658.22 crore for year under review as compared to Rs 1571.32 crore for year ended March 31, 2022.
For the year ended March 31, 2023, on the consolidated basis, the company has reported 8.57% rise in its net profit at Rs 111.10 crore as compared to Rs 102.33 crore for the previous year. Total income of the company increased by 69.61% at Rs 2665.86 crore for year under review as compared to Rs 1571.78 crore for year ended March 31, 2022.
| Company Name | CMP |
|---|---|
| Shree Renuka Sugar | 28.14 |
| Bajaj Hindusthan Sug | 18.80 |
| Triveni Engg. & Inds | 393.00 |
| Balrampur Chini Mill | 486.00 |
| Dalmia Bharat Sugar | 394.05 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: